Sinus Tract Next to Tenting Screw After Bone Graft and Implant Placement: How to Resolve?
After 5 months of uneventful healing of implants, I now see a small lesion resembling a sinus tract that is present in the immediate vicinity of one tenting screw.The postSinus Tract Next to Tenting Screw After Bone Graft and Implant Placement: How to Resolve? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - April 11, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Surgical Source Type: news
Ridge Augmentation: Thoughts about Bond Apatite synthetic Bone Graft?
Any thoughts on using synthetic bone augmentation materials, like Bond Apatite for lateral ridge augmentation or ridge widening?The postRidge Augmentation: Thoughts about Bond Apatite synthetic Bone Graft? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - April 6, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Regenerative Source Type: news
7 medtech stories we missed this week: March 23, 2018
[Image from unsplash.com]From Medizone’s evaluation deal to Advantis Medical Imaging getting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Medizone inks AsepticSure evaluation deal with commercial cleaning products maker Innovasource
Medizone announced in a March 22 press release that it has signed a product evaluation agreement with Innovasource. As part of the agreement, Innovasource will be leading the evaluation of the AsepticSure system and compare it to existing cleaning practices in a number of facilities and settings. AsepticSure is designed ...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Food & Drug Administration (FDA) Hospital Care Imaging Implants Patient Monitoring Regulatory/Compliance Respiratory advantismedicalimaging aziyobiologics Balt endospan Medizone MedTech Olympus Respiratory Motion Source Type: news
LifeNet Health launches unique, life-saving vascular allograft
AngioGraft® Aortoiliac Artery, the first to offer pressurized sizing, offers unparalleled efficiency and precision in aortic reconstruction
VIRGINIA BEACH, Va., March 19, 2018 -- (Healthcare Sales & Marketing Network) -- LifeNet Health today announc... Devices, Cardiology, Surgery, Product Launch LifeNet Health, AngioGraft, Aortoiliac Artery, vascular allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news
Cerapedics wins FDA IDE nod for P-15L bone graft trial
Cerapedics said today it won FDA investigational device exemption approval to launch a clinical trial examining the safety and efficacy of its P-15L Peptide Enhanced bone graft.
In the trial, the Wesminster, Colo.-based company will explore the use of the P-15L graft as it compares to autografts in transforaminal lumbar interbody fusion procedures meant for treating degenerative disk disease.
“Prior research of this proprietary P-15 technology has demonstrated potential benefits in fusion rates, neurological outcomes and safety in cervical and lumbar fusions. We are pleased to participate in a new study evaluating w...
Source: Mass Device - March 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Regulatory/Compliance Spinal Cerapedics Inc. Source Type: news
Cerapedics Receives FDA IDE Approval to Initiate Study of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery
Pivotal study to evaluate next-generation synthetic small peptide technology (P-15) compared to autograft in most common spine procedure
WESTMINSTER, Colo., March 14, 2018 -- (Healthcare Sales & Marketing Network) -- Cerapedics, a privately-held orthob... Devices, Orthopaedic, FDA Cerapedics, orthobiologic, i-FACTOR, Peptide Enhanced Bone Graft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 14, 2018 Category: Pharmaceuticals Source Type: news
Autogenous Bone: Most Effective Material?
Two recent studies show good results with autogenous bone grafts, long considered the most effective material in bone regeneration procedures.The postAutogenous Bone: Most Effective Material? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - March 13, 2018 Category: Dentistry Authors: osseonews Tags: Implant News Surgical Source Type: news
Osteochondral allograft transplantation effective for certain knee cartilage repairs
(American Orthopaedic Society for Sports Medicine) Isolated femoral condyle lesions account for 75 percent of the cartilage repair procedures performed in the knee joint, and physicians have a variety of techniques to consider as part of surgical treatment. Osteochondral allograft transplantation (OCA) is a valuable and successful approach for this condition, as described by research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in New Orleans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 10, 2018 Category: International Medicine & Public Health Source Type: news
Medtronic wins one lawsuit, settles state AG probes over Infuse
Medtronic (NYSE:MDT) said a shareholder lawsuit brought over its Infuse bone-growth protein is over, after the U.S. Supreme Court declined to review the case.
Approved in 2002 for use in spinal fusion surgery, Infuse at one point had annual sales of nearly $1 billion. The bone-grafting product has since been linked to abnormal bone growth, certain cancers and male reproductive problems. Fridley, Minn.-based Medtronic has been accused of not only downplaying the product’s risks but also promoting it for off-label use.
The derivative lawsuit, brought in March 2012 by investor Charlotte Kokocinski in the U.S. District Cou...
Source: Mass Device - March 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Orthopedics Regenerative Medicine Medtronic Source Type: news
Collaboration Is Key in Bioventus ’s Path Toward Innovation
Durham, NC-based Bioventus is hoping to expand its position in the allograft market through a collaboration with LifeLink Foundation. The accord will have the companies work together to co-develop a next-generation bone allograft solution for use in spine and trauma surgery.
Bivoentus specializes in orthobiologic products for bone healing, bone graft, and knee osteoarthritis.
“LifeLink is a fully equipped tissue bank,” Samson Tom, vice president of research and development at Bioventus, told MD+DI. “Here at Bioventus, we have significant infrastructure, but we are not a tissue bank. We recognize partnering with a ti...
Source: MDDI - February 27, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Purulent discharge and radiolucent area around implant: Advice?
I placed an implant at area 32 with bone graft. Saw patient after 18 days and there is purulent discharge and a radiolucent area around the implant. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - February 19, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Surgical Source Type: news
Distal tibial allograft reconstruction and Latarjet may offer similar outcomes for recurrent anterior shoulder instability
According to a study published online in The American Journal of Sports Medicine, fresh distal tibia allograft (DTA) reconstruction and the Latarjet procedure may offer similar outcomes for recurrent anterior shoulder instability. (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - February 10, 2018 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news
Detecting and treating dnDSA early preserves allograft function
(Children's National Health System) Monitoring and treating de novo donor-specific antibodies before they could cause graft damage helped to decrease dnDSA in a majority of pediatric kidney transplant recipients at Children National Health System and prevented graft failure in the first few years. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 5, 2018 Category: International Medicine & Public Health Source Type: news
Finland ’ s BBS-Bioactive Bone Substitute plans $10m IPO
BBS-Bioactive Bone Substitutes said today that’s its planning for an initial public offering later this year it hopes will bring in some $10 million.
Oulu, Finland-based BBS said it plans to list 1.5 million shares at €5.50 apiece beginning Feb. 5 for gross proceeds of €7.7 million, or roughly $9.6 million. The shares, due to trade on the First North Finland and NASDAQ First North Sweden exchanges, would represent about 23.9% of BBS’s total shares if the flotation is fully subscribed.
Based on proteins extracted from reindeer bone, BBS’s Artebone is designed to be injected to the site of a bone frac...
Source: Mass Device - January 31, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Orthopedics Regenerative Medicine Wall Street Beat bioactivebonesolutions Source Type: news
Socket grafting after extraction of an infected endodontic tooth?
How do you treat and clean the socket after extraction of an infected endodontic tooth and prepare it for the bone graft for ridge preservation? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - January 30, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Clinical Questions Source Type: news
